MNTA

Buyout Excitement Is Already Priced Into Momenta Pharmaceuticals

By David Moadel, InvestorPlace Contributor
Momenta Pharmaceuticals stock was thrust into the financial headlines and might look tempting, but don't forget that price is king.

Momenta Pharmaceuticals News: MNTA Stock Rockets 69% on JNJ Deal

By William White, InvestorPlace Writer
Momenta Pharmaceuticals (MNTA) news for Wednesday includes a deal with Johnson & Johnson (JNJ) sending MNTA stock rocketing higher.

Mylan Stock is One Stumble Away From a Big Technical Pullback

By James Brumley, InvestorPlace Feature Writer
Thinking about buying Mylan stock? You may not want to just yet. It's toying with a support line that, if it snaps, could open the selling floodgates.

How Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Recover

By Vince Martin, InvestorPlace Contributor
Teva Pharmaceutical desperately needs a new CEO - and a new strategy to boot - to stop the steady decline in TEVA stock.

No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed

By James Brumley, InvestorPlace Feature Writer
Teva Pharmaceutical (TEVA) has more upside than most investors realize. Look past the Copaxone debacle, and TEVA stock is promising.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast

By Joseph Hargett, InvestorPlace Contributor
Despite Teva's (TEVA) gains on earnings and rival delays, TEVA stock is still facing impassive sentiment and broad selling pressure.